Clinical trial

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery…

NCT00103181 · NSABP Foundation Inc, Other · Completed

Key facts

NCT number NCT00103181
Title Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Official title A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women With Stage 0, I, or II Breast Cancer
Lead sponsor NSABP Foundation Inc, Other
Collaborators National Cancer Institute (NCI) NIH Radiation Therapy Oncology Group SWOG Cancer Research Network
Status Completed
Study type Interventional
Conditions Breast Cancer
Intervention type Radiation
Interventions 3-dimensional conformal accelerated partial breast irradiation, brachytherapy, whole breast irradiation, MammoSite or other single-entry intracavitary device
Enrollment 4,216
Start date Mar 1, 2005
Primary completion Aug 1, 2018
Completion Aug 1, 2018
First posted Feb 8, 2005
Last update posted Apr 14, 2022
Countries Canada, Ireland, Israel, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies